(Q84560637)
Statements
Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes (English)
Neil R McMullin
Charles E Wade
Tina G Nielsen
Rolf Rossaint
Bruno Riou
Sandro B Rizoli
Yoram Kluger
Brian Warren
Bartholomew J Tortella
NovoSeven Trauma Study Group